Skip to content

Drug interactions

Buprenorphine + Gilteritinib

Severity: Moderate

Buprenorphine and Gilteritinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Gilteritinib can prolong the QT interval and buprenorphine has a modest additional effect. Combined use may raise the risk of torsades de pointes, particularly with electrolyte disturbance.

What this interaction means in plain words

Buprenorphine and Gilteritinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Buprenorphine belongs to Musculoskeletal; Gilteritinib belongs to Oncology.

Evidence level: Low

Why it happens

Additive QTc prolongation.

What to do

Monitor ECG at baseline and during therapy and keep potassium and magnesium in range. Reduce or interrupt gilteritinib per label if QTc becomes markedly prolonged.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine and Gilteritinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine with Gilteritinib?

MediHelp rates the interaction as moderate. Buprenorphine and Gilteritinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Gilteritinib can prolong the QT interval and buprenorphine has a modest additional effect. Combined use may raise the risk of torsades de pointes, particularly with electrolyte disturbance.

How serious is the interaction between Buprenorphine and Gilteritinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG at baseline and during therapy and keep potassium and magnesium in range. Reduce or interrupt gilteritinib per label if QTc becomes markedly prolonged.

What other medicines interact with Buprenorphine?

MediHelp also lists interactions of Buprenorphine with, for example, Alvimopan, Calcium / magnesium / potassium / sodium oxybates, Olanzapine / samidorphan. The full list is on the Buprenorphine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in